Cefprozil and Pharyngitis - a phase IV clinical study of FDA data

Summary:

Pharyngitis is reported as a side effect among people who take Cefprozil (cefprozil), especially for people who are male, 10-19 old, have been taking the drug for < 1 month also take Humira, and have Crohn's disease.

The phase IV clinical study analyzes which people have Pharyngitis when taking Cefprozil. It is created by eHealthMe based on reports of 1,051 people who have side effects when taking Cefprozil from the FDA, and is updated regularly.

What is Cefprozil?

Cefprozil has active ingredients of cefprozil. It is often used in sinusitis. eHealthMe is studying from 1,103 Cefprozil users. Check the latest studies of Cefprozil.

What is Pharyngitis?

Pharyngitis (inflammation of the pharynx, causing a sore throat) is found to be associated with 1,219 drugs and 1,209 conditions by eHealthMe. Check the latest studies of Pharyngitis.

On Jul, 25, 2026

1,051 people reported to have side effects when taking Cefprozil.
Among them, 12 people (1.14%) have Pharyngitis.

Among these 12 people:

How long have people been on Cefprozil when they have Pharyngitis? *

What is the gender of people who have Pharyngitis when taking Cefprozil? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Pharyngitis when taking Cefprozil? *

What are other drugs people take besides Cefprozil? *

What are other side effects people have besides Pharyngitis? *

Splenomegaly (enlargement of spleen): 8 people, 66.67%
Lymphoma (cancer that begins in immune system cells): 8 people, 66.67%
Oropharyngeal Pain: 8 people, 66.67%
Diarrhea Haemorrhagic: 8 people, 66.67%
C-Reactive Protein Increased: 8 people, 66.67%
Microcytic Anaemia (a generic term for any type of anaemia characterized by small red blood cells): 8 people, 66.67%
Blood Uric Acid Increased: 8 people, 66.67%
Blood Lactate Dehydrogenase Increased: 8 people, 66.67%
Blood Alkaline Phosphatase Increased: 8 people, 66.67%
Otitis Media Acute (rapid inflammation of the middle ear): 8 people, 66.67%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 9 people, 75.00%
Stress And Anxiety: 8 people, 66.67%
Otitis Media (inflammation of the middle ear): 8 people, 66.67%
Nervous System Disorder (a general class of medical conditions affecting the nervous system): 8 people, 66.67%
Lymphadenitis (inflammation or enlargement of a lymph node): 8 people, 66.67%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 2 people, 16.67%
Dyspnea (difficult or laboured breathing): 2 people, 16.67%
Diabetic Gastroparesis (paralysis of the muscles of the stomach caused by diabetes): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Cefprozil and have Pharyngitis?

- Check whether Pharyngitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefprozil:

Cefprozil (1,103 reports)

Pharyngitis treatments and more:

Pharyngitis (21,038 reports)

Browse all side effects of Cefprozil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pharyngitis:

Pharyngitis (1,219 drugs)

Browse all the conditions that are associated with Pharyngitis:

Pharyngitis (1,209 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefprozil (the active ingredients of Cefprozil) and Cefprozil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.